REQUEST A DEMO
Total
USD $0.00
Search more companies

Allium Upi UAB (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Allium Upi UAB Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Allium Upi UAB is an enterprise located in Lithuania, with the main office in Vilnius. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on August 21, 2000. The total number of employees is currently 15 (2025). From the latest financial highlights, Allium Upi UAB reported a net sales revenue increase of 25.77% in 2024. The enterprise’s net profit margin decreased by 2.91% in 2024.

Headquarters
Kintu g. 11
Vilnius; Vilnius county; Postal Code: LT-09301

Contact Details: Purchase the Allium Upi UAB report to view the information.

Basic Information
Total Employees:
Purchase the Allium Upi UAB report to view the information.
Registered Capital:
Purchase the Allium Upi UAB report to view the information.
Financial Auditors:
Purchase the Allium Upi UAB report to view the information.
Incorporation Date:
August 21, 2000
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Allium Upi UAB report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
25.77%
Total operating revenue
25.77%
Net Profit (Loss) for the Period
-14.22%
Total Equity
181.38%
Net Profit Margin
-2.91%
Return on Equity (ROE)
-146.99%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?